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Abstract 
Background: Bacterial vaginosis (BV) is a polymicrobial syndrome in which a decrease in vaginal acidity and 
concentration of lactobacilli is accompanied by an increase of other pathogenic micro-organisms. The distribution of 
lactic acid bacteria in vaginal environment of Ethiopian women has not been documented. 
Objective:To assess the frequency of bacterial vaginosis in women visiting a gynecological clinic in Addis Ababa and 
to characterize the most common lactic acid bacteria isolated from vaginal fluid. 
Methods: Vaginal samples from a total of 100 women aged between 18 and 60 years and visiting a gynecological 
clinic in Addis Ababa were collected between January and June, 2008 and analyzed for their microbial flora. Their 
Nugent score was determined microscopically and Lactic acid bacteria were isolated, characterized and their drug 
resistance determined. 
Results: BV frequency among these study women was 32%. Only 15% were symptomatic as detected by the presence 
of malodor or abnormal discharge. The majority (44%) was in the age group of 18-30 years and less than a quarter of 
them had BV. It was also detected in about a third of women belonging to the two major religious denominations had 
BV. The frequency of BV among pregnant women was low. The frequency of BV in women with prior abortion was 
slightly higher than 1/3. A total of 350 lactic acid bacterial isolates were obtained and 40% of them belonged to 
Lactococcus species. Lactobacillus, Leuconostoc, and Pediococcus were encountered at different frequencies. 
Resistance was seen against all drugs at various frequencies among the LAB (Lactic Acid Bacteria) isolates. 
Resistance of LAB to all antibiotics tested ranged between 20% and 42%, and the least resistance was noted against 
vancomycin. All women who had been positive for bacterial vaginosis were accordingly treated. 
Conclusion: Bacterial vaginosis may contribute to adverse reproductive outcomes. Prevalence of bacterial vaginosis in 
this study compares well with other African studies. The species richness and relative abundance of vaginal lactic acid 
bacteria in this study may be considered to design better probiotic products as bacterial replacement therapy.  [Ethiop. 
J. Health Dev.  2010;24(3):198-204] 
 
Introduction 
The adult human vagina is a complex ecosystem 
containing an abundance of microorganism. The vagina 
and its unique microflora form a finely balanced 
ecosystem, with the vaginal environment controlling the 
presence of microbes and the microflora, in turn, 
controlling the vaginal environment (1). Vaginal 
microbial communities play a role in colonization 
resistance, protection against invasion by pathogens and 
dominance by potentially pathogenic species among the 
normal flora. Thus, perturbations of the vaginal 
community structure may predispose individuals to 
various infectious diseases (2).  
 
Bacterial vaginosis is a polymicrobial syndrome in which 
a decrease in vaginal acidity and concentration of 
lactobacilli is accompanied by an increase of other 
pathogenic micro-organisms such as Gardnerella 
vaginalis and Mobiluncus spp.  (3). According to Zhou et 
al., (1), lactobacilli have been thought to be the 
predominant members of normal post pubertal vaginal 
microflora. However, a diverse array of other bacteria 
such  as  Staphylococcus, Ureaplasma, Corynebacterium,  
 
Streptococcus, Peptostreptococcus, Gardnerella, 
Bactericides, Mycoplasma, Enterrococcus, Escherichia, 
Veiloella, Bifidobacterium and Candida can be present 
but in much lower numbers. A general opinion is that 
species of the Lactobacillus acidophilus complex 
constitute most of the healthy vaginal Lactobacillus flora. 
However, a variety of other lactobacilli have been 
encountered (4). 
 
In healthy vagina, lactobacilli produce hydrogen peroxide 
and lactic acid.  These lower the vaginal pH to a level 
inhospitable to many other bacteria such as the anaerobic 
Gram-negative rods Bactericides and Prevotella, genital 
mycoplasmata, and Gardenerella vaginalis, Neisseria 
gonorrhoeae and Chlamydia trachomatis. A low pH has 
been shown to have direct microbicidal and virucidal 
effect (4). Lactobacilli can also adhere onto vaginal 
epithelial cells thus blocking the attachment of any 
pathogenic bacteria onto these cells. Lactobacilli are 
known to produce biosurfactants, bacteriocins and 
coaggregation molecules, all of which contribute to the 
maintenance of a healthy vaginal micro-environment (5). 
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Hydrogen peroxide inhibits the growth of Bactericides, 
Gardnerella, Mobiluncus, Mycoplasma and other vaginal 
organisms also react with halide ions in the presence of 
vaginal peroxidase as part of the H2O2-halide peroxidase 
antibacterial system (6, 7). Various studies show that 
H2O2 producing lactobacilli strains are found in about 
96% of women with normal vaginal microflora but only 
in about 6% of women with bacterial vaginosis 
suggesting its protective role against bacterial vaginosis 
and other sexually transmitted diseases (8, 9).  
 
The microorganisms normally present in the human 
vagina play a key role in preventing successful 
colonization by undesirable organisms, including those 
responsible for bacterial vaginosis, yeast infections, 
sexually transmitted diseases and urinary tract infections 
(10). Moreover, epidemiologic studies have clearly 
indicated that abnormal vaginal microbial communities 
and lower genital tract infections were significantly 
associated with an increased risk of sexually transmitted 
diseases including HIV/AIDS (11). 
 
Bacterial vaginosis (BV) is a clinical syndrome 
presenting with a malodorous vaginal discharge and 
increased vaginal pH. Diagnosis has been made based on 
clinical Amsel criteria and direct Gram stain of vaginal 
secretions. Generally, factors such as frequency of sex, 
active sexual behavior (12), menstrual cycle (13) 
contraceptive use and douching (14) have been given as 
major reasons for the instability of vaginal flora in 
reproductive age group women. The treatment of 
bacterial vaginosis with metronidazole of 400 mg or 
clindamycin of 300 mg should be administered twice 
daily per os for 5 to 7 days with or without local 
treatment with gel or cream preparations. Pregnant 
women who are at risk of developing premature rupture 
of membranes and pre-term labour patients who actually 
have the infection, and or those who are to undergo 
pelvic and abdominopelvic operations are the 
beneficiaries of treatment schedules. Nevertheless, it is to 
be noted that relapses should be anticipated as these 
drugs are ineffective against Mycoplasma hominis and 
the continued presence of yet other unidentified 
microorganisms (15, 16, 17). 
 
In women of childbearing age, bacterial vaginosis (BV) 
is the most common cause of vaginitis. In BV, normal 
vaginal flora, consisting of hydrogen peroxide-producing 
lactobacilli, are replaced by Gardnerella vaginalis, 
Mycoplasma hominis, Mobiluncus species, and anaerobic 
gram-negative rods (18). Recombinant lactobacilli are 
engineered to express HIV-1 fusion inhibitor with potent 
neutralizing activity and this is believed to contribute to 
the development of a live microbial (topical) microbicide 
against HIV-1 infection (19). 
 
The main aim of this study was to assess the prevalence 
of bacterial vaginosis in women visiting a gynecological 
clinic in Addis Ababa and to identify and characterize the 
most common Lactic acid bacteria isolated from vaginal 
fluid. Further more, the study assessed the distribution of 
drug resistance among the dominant lactic acid bacteria 
isolates from vaginal microflora.  
 
Methods 
A total of 100 women who were quasi randomly selected 
and aged between 18 and 60 years were considered in the 
study. These were outpatient clients visiting Monday, 
Wednesday and Friday Gynaecological and Obstetrical 
clinical services of a Higher Clinic in Addis Ababa from 
January 2008 to June 2008. The women were residents of 
Addis Ababa and information regarding demographic 
characteristics, medical, surgical, sexual and reproductive 
history was recorded. All the enrolled patients did not 
have an earlier established clinical and microbiological 
diagnosis of bacterial vaginosis. Those who did not give 
their consent or had and/or gave history suggestive of 
clinical signs and symptoms of urethritis, vulvovaginitis, 
cervicitis, endometritis and salpingitis were excluded 
from the study. All the patients who were found to have 
bacterial vaginosis were eventually treated for the 
infection by the gynaecologist; and the intervention was 
designed in such a way that it will not affect patient 




A total of 100 vaginal specimens were collected from the 
patients. Sampling of the specimen was carried out by the 
gynecology and obstetrics specialist through insertion of 
a sterile cotton swabs into the vaginal lateral wall. The 
swab was rotated against the vaginal wall at the mid 
portion of the vault and was carefully removed. The 
samples were separately put in sterilized test tubes and 
transported to the microbiology laboratory of the Institute 
of Pathobiology, AAU within two hours.   
 
Determination of Nugent score  
The swab was first used for anaerobic culture preparation 
by streaking on the MRS agar plates.  The same swab 
was used to prepare a smear on a glass slide for Gram 
staining.   The microbiological evaluation of vaginal 
microflora pattern was made using Nugent scoring 
system (20), based on counting bacterial cell types on 
Gram stained slides of vaginal smears. 
 
The smear was interpreted as normal (score 0-3) when 
the lactobacilli morphotype was present alone or in 
combination with very few Gardnerella morphotype 
(Small Gram-negative rod). When lactobacilli were 
found in low number and Gardnerella and Mobiluncus 
groups were seen in considerable large number.  This 
was interpreted as intermediate (score of 4–6). When a 
more mixed flora, including not only the Gardnerella 
morphotype but also other Gram-negative and Gram-
positive bacteria, such as curved rods, Gram negative 
rods and Gram-positive cocci, are present and when the 
Lactobacillus morphotype was completely absent, the 
smear was interpreted as consistent with BV (score 7-10). 
(20).  
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Number of bacteria between 1 and 30 per field of 
microscope was taken as approximate representative of 
bacteria in the whole field. The amounts of different 
bacterial morphotypes were then transformed to intervals 
in accordance with Nugent scoring system. Finally, the 
points achieved from the amount of different bacterial 
morphotypes were added together.   
 
Isolation and Identification of Lactic Acid Bacteria 
(LAB) 
Lactic acid bacteria were isolated on MRS (de Mann 
Rogosa Sharp) agar plates after swabbing on the plates 
and incubating using anaerobic jar at 37oC for 48-72 
hours. Five colonies were randomly selected from each 
MRS agar plate. The colonies were isolated and purified 
using Brain Heart Infusion (BHI) broth. The isolates 
were grouped as lactic acid bacteria based on their Gram 
reaction, colony morphology, catalase reaction and 
homofermentative/heterofermentative test in MRS broth 
containing 5% glucose.   
 
Antibiotic Susceptibility Test  
The antimicrobial activities of the isolates were 
quantified by disc diffusion method as suggested by 
Bauer et al., (21).  A well-isolated colony was selected 
from MRS agar plate and transferred into a tube 
containing sterile BHI broth. The inoculated broth was 
incubated at 37oC for 24 hours. Broth culture was 
swabbed on the entire dried surface of a Mueller-Hinton 
agar plate. Eight antibiotic discs consisting of Ampicillin 
(10mg), Clindamycin (2mg), Gentamycin (10mg), 
Kanamycin (30mg), Methicillin (5mg), Penicillin (10 
unit), Streptomycin (10mg) and Vancomycin (30mg) 
were placed on the surface of the agar plate using disk 
dispenser and incubated for 24 hours at 37°C. The 
diameter of the zones of complete inhibition was 
measured to the nearest whole number in millimeter, 
using transparent ruler. Intermediate readings were 
considered sensitive for the purpose of interpretation. 
 
Ethical Consideration 
Ethical clearance was obtained from ethical Clearance 
Committee of Biology Department in AAU.  The 
subjects were included in the study after the purpose of 
the study was clearly explained to all subjects and they 
were included in the study after they consented.  Any 
patient positive for BV was treated by the physician. 
Results 
The microbiological evaluation of vaginal microflora 
pattern was made using Nugent scoring system that was 
based on counting the bacterial cell types on the Gram 
stained slides of vaginal smears (Table 1). According to 
this study large Gram-positive bacilli were dominantly 
present in 42% of the women. The typical appearance of 
the organisms identified as having the Lactobacillus 
morphotype was evident for the absence of bacterial 
vaginosis and generally  interpreted as normal flora 
(score 0-3). 
In 26% of the women, two or three bacterial 
morphotypes were evident. Stains showing the presence 
of few Lactobacillus and many Gram-negative 
morphotypes (Gardnerella and/or Mobiluncus 
morphotype) were interpreted as intermediate flora (score 
4-6).  
 
Thirty two percent of the women in relation to Table 1 
showed complete absence or low presence of 
Lactobacillus morphotype and a smear consistent with 
BV (score 7-10). The flora in this group of women was 
mainly composed of small Gram-negative organisms of 
the Gardnerella morphotype and curved Gram-negative 
rods (Mobiluncus morphotype). 
 
LAB were isolated randomly from specimen cultures of 
70 women (Table 3). Thirty women did not have genital 
cultures due to cases of either contamination or absence 
of growth.  A total of 350 randomly picked colonies were 
purified and analyzed. Gram positive, catalase negative, 
cocci or rod shaped isolates which formed single, paired, 
tetrad or long chain colony arrangements were 
considered to belong to the lactic acid bacteria. These 
were classified based on their colony morphology and 
fermentation test results to one of the following four 
genera: Lactobacillus, Lactococcus, Leuconostoc, and 
Pediococcus. 
 
The resistance pattern of the isolates against different 
antibiotics is presented in Table 4. It was found out that 
the resistance of LAB to all antibiotics was in the range 




Understanding the structure of normal vaginal 
communities is very important for at least two reasons. 
First, some of these microbes may have physiological 
functions that directly affect the health of women. They 
play a role in colonization resistance and providing 
protection against invasion by pathogens. Second, change 
of the community structure of vaginal ecosystem may 
predispose individuals to various infectious diseases (1, 
2).  
 
In this study, BV frequency in the study population was 
32%. Although the sample size was not large enough to 
make reasonable comparisons, observations in this study 
variably compare with the studies that have specifically 
assessed BV prevalence among African settings. Demba 
et al. (22) reported prevalence of 47.6% in the Gambia, 
20–23% in Burkina Faso and Malawi, 37% in Tanzania 
and 49% in Kenya populations. BV appears to be more 
common in Africa than in industrialized countries (23, 
24). The reasons for these apparent differences are not 
still fully understood. Researchers have suggested, as a 
possible explanation, that levels of education and other 
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Table 1: Scoring Vaginal Gram’s Stain for Bacterial Vaginosis (Nugent et al, 1991)  
Scale Lactobacillu
s 
Score  Gardnerella Score Mobiluncus Score 
4+ = >30 organism/ field 4+ 0 4+ 4 4+ 2 
3+ = 5-30 organism/ field 3+ 1 3+ 3 3+ 2 
2+ = 1-4 organism/ field 2+ 2 2+ 2 2+ 1 
0 or 1 + = < 1 organism/ 
field 
0 4 0 0 0 0 
 
Of the women who were included in the study, only 15% 
were clinically suspected to have bacterial vaginosis. 
This fact was detected by the presence of fishy malodor 
or abnormal discharge as confirmed by the physician 
during clinical diagnosis. In other studies, women with 
BV often reported no signs or symptoms at all and up to 
50% of women were asymptomatic (2). These 
asymptomatic women are less likely to seek treatment 
and thus are more likely to acquire other serious STDs 
including HIV/AIDS (9, 23). Different studies reported 
that changes in structure and composition of vaginal 
ecosystem are influenced by age, time in menstrual cycle, 
pregnancy, infections, methods of birth control, 
frequency of sexual activities as well as number of sexual 
partners, various habits and practices such as douching 
and pH of the vaginal fluid (10). 
 
Due to the small sample size, we could not associate BV 
with a given age group although it has higher frequency 
among the age group of 31-40 years. Some researchers 
have previously reported that BV is more common 
among younger women (25), while others observed that 
the risk for BV increased with age (2).The finding in our 
setup was quite similar with the latter observation. 
 
It may be inappropriate to compare the frequency of BV 
among religious dominations because of lack of 
comparability in the number of samples. However, it 
could be said that about a third of the patients in both 
groups had BV (Table 2). A study in India showed BV 
frequency was higher among the Christian population 
(26). Certain risk factors such as genital hygiene 
practices that are known to be associated with BV may 
vary with religion (25). Similarly we had a low number 
of unmarried patients to make a reasonable comparison, 
although a third of the patients in both marital status 
groups had BV. It is worth noting, however, that 24% of 
the married or single patients had asymptomatic BV.  
 
The frequency of BV among pregnant women was low 
(Table 2). On the other hand, among the 89 non-pregnant 
women, a total of 55 had intermediate vaginal flora or 
BV. In different studies pregnant women with BV are 
considered to be at increased risk for having preterm 
birth, infants with low birth weight and premature rupture 
of the membranes (15, 23). Therefore, screening pregnant 
women for bacterial vaginosis may help to identify a 
group at higher risk for preterm birth and to offer 
adequate treatment (27).   
 
The majority of women (81%) had no abortion history 
and about 1/3 of them had BV (Table 2). Although the 
number was low, the frequency of BV in women with 
prior abortion was slightly higher than one third. A 
growing body of literature showed an increased risk of 
spontaneous abortion among pregnant women with BV 
(5, 18). Moreover, studies found significant associations 
between bacterial vaginosis and the use of contraceptive 
(28). Only 11 of the patients in this study used any one of 
the contraceptive methods. The frequency of use of any 
of the contraceptive methods was <4%. Among the 89 
non-users, more than half had either intermediate vaginal 
flora or BV. In our study the majority of contraceptive 
users had dominant intermediate flora and BV was seen 
only in two of the four recorded oral contraceptive users. 
Since, bacterial vaginosis is common among women in 
the reproductive age group who are also the most likely 
contraceptive users, any association between BV and 
contraceptive use could be the result of the age structure 
of the women (18). 
 
The most predominant isolates were long chained, cocci-
shaped homofermentative lactococci which comprised 
40% of the 350 isolates. As to Todorov et al (29) stated, 
Lactococcus lactis, isolated from vaginal secretions, 
produced a bacteriocin that caused death to Gram 
positive and Gram negative bacteria. Lactobacilli 
constituted 29% of the isolates. Of these lactobacilli, 
84% were homofermentative and the rest were 
heterofermentative. The dominance by homofermentative 
lactobacilli was indicative of the production of more acid 
from fermentable sugars which may come from glycogen 
in the vaginal environment. Pediococci made up of 23% 
of the total LAB colonies. Finally, colonies which were 
cocci but showed hetrofermentative nature were 
identified as Leucnostoc and made up 8 % of the total 
LAB.   
 
A considerably different proportion of LAB isolates were 
encountered in this study. The species richness and 
relative abundance of lactic acid bacteria in vagina is 
documented (23, 30). According to these studies, though 
a large number of lactic acid bacteria colonize the vagina, 
their genera and species distributions may be different in 
women of geographically separated communities. 
Moreover, the knowledge of species richness and relative 
abundance of vaginal lactic acid bacteria may lead to the 
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Table 2: Prevalence of BV among outpatients in Addis Ababa (Jan., 2008-July, 2008) Socio-demographic and 
Clinical Status of Women Using Nugent’s Criteria 
  Total Normal  Intermediate BV 
Age group 18-30 44 23 11 10 
31-40 27 10 3 14 
41-50 21 8 6 7 
>50 8 1 6 1 
Pregnancy Pregnant 11 6 3 2 
Non-pregnant 89 36 23 30 
Abortion Previous Abortion 19 6 6 7 
Non abortion 81 36 20 25 
Contraceptive usage Loop 4 1 3 0 
Injection 3 1 2 0 
Pills 4 0 2 2 
Non-user 89 40 19 30 
Religious denomination Christian 62 29 12 21 
Muslim 38 13 14 11 
Marital status Married  93 38 24 31 
Single 7 4 1 2 
Clinical case Asymptomatic 85 40 21 24 
Symptomatic 15 2 5 8 
 
Table 3: Microscopic characteristics, KOH and Catalase Test Results of Lactic Acid Bacteria Isolated from 
Women’s Vaginal Fluid in Addis Ababa (Jan., 2008-July 2008) 












Lactococci Cocci Long Chain
  
Homofermentative 
 Positive Negative 
140 
(40%) 
Lactobacilli Rod Single 84% Homo- 20% 
Hetro-fermentative Positive Negative 
100 
(28.57%) 










Table 4:  The Antimicrobial Activity of LAB Isolates from Women’s Vaginal Fluid in Addis Ababa (Jan., 2008-
July 2008) 
 Amp Cli Gen Kan Met Pen Str Van 
Resistant 16 (26.7%) 25 (41.7%) 16 (26.7%) 18 (30%) 24 (40%) 20 (33.3%) 22 (36.7%) 12 (20%) 
Intermediate 12 (20%) 5 (8.3%) 2 (3.3%) 0 0 34 (56.7%) 0 0 
Sensitive 32 (53.3%) 30 (50%) 42 (70%) 42 (70%) 36 (60%) 6 (10%) 38 (63.3%) 48 (80%) 
Where: Amp, Ampicillin; Cli, Clindamycin; Gen, Gentamycin; Kan, Kanamycin; Met, Methicillin; Pen, Penicillin; Str, 
Streptomycin; Van, Vancomycin 
 
Generally speaking, an inverse relationship was observed 
between the presence of Lactobacillus morphotype and 
Gardnerella morphotype. When the Lactobacillus 
morphotype was dominant, the Gardnerella morphotype 
was usually absent. When the Gardnerella morphotype 
was dominant the quantity of the Lactobacillus 
morphotype was generally diminished. As per the  result 
of this study, a comparison of vaginal micro-flora isolates 
with Nugent's score showed significant positive 
associations with BV and a significant negative 
association with the presence of lactobacilli or vice versa. 
These findings generally coincide with findings in other 
studies (20, 22), since the method employed for the 
Nugent's score is based on the observation of BV-
associated bacterial morphotypes. 
 
Resistance was seen against all drugs at various 
frequencies among the LAB isolates. In general, it can be 
said that resistance of LAB to all antibiotics tested ranged 
between 20% and 42%, and the least resistance was 
noted against vancomycin. It is very important to know 
about the antimicrobial susceptibility or resistance of 
LAB isolated from human vagina to predict the behavior 
of an applied probiotic or to consider the application of 
probiotic strains, along with antibiotics, in women with 
bacterial vaginosis to allow the restoration of the normal 
genital flora (23). For example, a bacteriocin-producing 
Lactococcus lactis was effective as a probiotic if taken 
with specific antibiotics and not with anti-inflammatory 
drugs and spermicides (29). In this regard, the 
performance of antimicrobial susceptibility testing of 
vaginal specimen may be considered as an effective 
guide for specific antimicrobial therapy for women with 
genital tract infections including BV (31). 
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Over 41.7% of our isolates were resistant to 
Clindamycin. This result has interesting meaning because 
Clindamycin is one of the most commonly prescribed 
antibiotics for the treatment of bacterial vaginosis (32). 
Thus, resistance of vaginal LAB against Clindamycin 
could be considered as an advantage because the LAB 
would function as resident probiotics even after treatment 
for BV. 
Bacterial vaginosis may contribute to adverse 
reproductive outcomes. The role of BV as an independent 
risk factor for pelvic inflammatory disease, infertility, 
preterm delivery and miscarriage is yet to be shown. The 
use of probiotic LAB against BV may probably 
contribute to minimize the public health profile of 
women at risk of reproductive morbidity and mortality.
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